ConocoPhillips (COP) Spending and interest coverage
- R&D / revenue · 12 months: Value 0.15%; Formula and calculation Research and development expense / revenue. Period ending 2025-12-31..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2025-12-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 0.15% | Research and development expense / revenue. Period ending 2025-12-31. $78.00M ÷ $51.82B × 100 ≈ 0.15% |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2025-12-31. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 78.00M USD | Research and Development Expense |
| Revenue | 51.82B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | |
| Operating income | (m) | |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $78.00M | $51.82B | (m) | (m) | (m) | 0.15% | (m) | (m) | (m) |
| 2024-12-31 | $81.00M | $49.42B | (m) | (m) | (m) | 0.16% | (m) | (m) | (m) |
| 2023-12-31 | $81.00M | $48.52B | (m) | (m) | (m) | 0.17% | (m) | (m) | (m) |
| 2022-12-31 | $71.00M | $61.05B | (m) | (m) | (m) | 0.12% | (m) | (m) | (m) |
| 2021-12-31 | $62.00M | $45.83B | (m) | (m) | (m) | 0.14% | (m) | (m) | (m) |
| 2020-12-31 | $75.00M | $18.78B | (m) | (m) | (m) | 0.40% | (m) | (m) | (m) |
| 2019-12-31 | $82.00M | $32.57B | (m) | (m) | (m) | 0.25% | (m) | (m) | (m) |
| 2018-12-31 | $78.00M | $36.42B | (m) | (m) | (m) | 0.21% | (m) | (m) | (m) |
| 2017-12-31 | $100.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $116.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $222.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $263.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $258.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $221.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $267.00M | $244.81B | (m) | (m) | (m) | 0.11% | (m) | (m) | (m) |
| 2010-12-31 | $230.00M | $189.44B | (m) | (m) | (m) | 0.12% | (m) | (m) | (m) |
| 2009-12-31 | $190.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $209.00M | $240.84B | (m) | (m) | (m) | 0.09% | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VALERO ENERGY CORP/TX (VLO) | United States | $110.282B | 10.72 |
| Marathon Petroleum Corp (MPC) | United States | $109.683B | 8.72 |
| Phillips 66 (PSX) | United States | $102.103B | 9.51 |
| IMPERIAL OIL LTD (IMO) | $60.241B | ||
| CVR ENERGY INC (CVI) | United States | $5.161B | 16.17 |
| ICAHN ENTERPRISES L.P. (IEP) | United States | $4.941B | -9.21 |
| Calumet, Inc. /DE (CLMT) | United States | $4.731B | -23.12 |
| Delek US Holdings, Inc. (DK) | United States | $4.096B | 13.87 |
| SunocoCorp LLC (SUNC) | United States | $3.977B | |
| CHEVRON CORP (CVX) | United States | $406.278B | 15.91 |